Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis
✍ Scribed by Michael A. van Es; Helenius J. Schelhaas; Paul W. J. van Vught; Nicola Ticozzi; Peter M. Andersen; Ewout J. N. Groen; Claudia Schulte; Hylke M. Blauw; Max Koppers; Frank P. Diekstra; Katsumi Fumoto; Ashley Lyn LeClerc; Pamela Keagle; Bastiaan R. Bloem; Hans Scheffer; Bart F. L. van Nuenen; Marka van Blitterswijk; Wouter van Rheenen; Anne-Marie Wills; Patrick P. Lowe; Guo-fu Hu; Wenhao Yu; Hiroko Kishikawa; David Wu; Rebecca D. Folkerth; Claudio Mariani; Stefano Goldwurm; Gianni Pezzoli; Philip Van Damme; Robin Lemmens; Caroline Dahlberg; Anna Birve; Rubén Fernández-Santiago; Stefan Waibel; Christine Klein; Markus Weber; Anneke J. van der Kooi; Marianne de Visser; Dagmar Verbaan; Jacobus J. van Hilten; Peter Heutink; Eric A. M. Hennekam; Edwin Cuppen; Daniela Berg; Robert H. Brown Jr; Vincenzo Silani; Thomas Gasser; Albert C. Ludolph; Wim Robberecht; Roel A. Ophoff; Jan H. Veldink; R. Jeroen Pasterkamp; Paul I. W. de Bakker; John E. Landers; Bart P. van de Warrenburg; Leonard H. van den Berg
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 136 KB
- Volume
- 70
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We studied 137 ulnar nerves and abductor digiti minimi (ADM) muscles in 70 patients with amyotrophic lateral sclerosis (ALS), and correlated the results with ADM strength graded on the Medical Research Council (MRC) scale, to address the potential value of a standardized neurophysiological assessmen
Glutamate levels were determined in the fasting plasma of 22 patients with early-stage primary amyotrophic lateral sclerosis (ALS) and compared to those of healthy and diseased controls. There was a significant increase (by approximately loo%, p < 0.0005) in the plasma glutamate of the ALS patients